Skip to main content

Table 5 Changes in perfusion parameters, RECIST-1.1 diameter, and tumour volume in epidermoid carcinomas (n = 16)

From: Evaluation of response to conventional chemotherapy and radiotherapy by perfusion computed tomography in non-small cell lung cancer (NSCLC)

  Partial response (n = 10) Stable disease (n = 6)
Baseline Control p value Baseline Control p value
Blood flow
(mL/100 mL/min)
176.1 ± 76.1 186.5 ± 106.4 0.775 234.9 ± 97.5 165.8 ± 108.7 0.010
Blood volume (mL/100 mL) 8.6 ± 3.3 5.9 ± 2.6 0.007 6.4 ± 2.8 5.2 ± 3.4 0.269
Permeability (mL/100 mL/min) 15.9 ± 6.9 11.1 ± 7.0 0.062 16.5 ± 11.5 6.7 ± 4.1 0.036
Mean transit time (s) 7.5 ± 3.6 5.3 ± 2.7 0.018 3.6 ± 1.7 5.3 ± 2.9 0.267
RECIST-1.1 diameter (mm) 54.5 ± 21.4 35.7 ± 15.7 0.002 62.5 ± 24.3 59.8 ± 23.9 0.082
Tumour volume (cc) 142.5 ± 171.8 56.1 ± 62.6 0.038 57.0 ± 4.6 22.5 ± 18.9 0.021
  1. RECIST Response evaluation criteria in solid tumours
  2. Significant p values are in bold